IP Library Granted Patent US 8,445,281
Granted Patent B2
US 8,445,281 · App. 12/818,055 · Granted May 21, 2013

In vitro exposure of immature oocytes to BDNF enhances generation of embryonic stem cells

Inventors: Kazuhiro Kawamura (Akita, JP); Aaron J. W. Hsueh (Stanford, CA); Sabine M. Mulders (Oss, NL)
Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,445,281
App. No.
12/818,055
Granted
May 21, 2013
Kind
B2
Abstract

Compositions and methods are provided for enhancing the survival and promoting the maturation of mammalian oocytes, zygotes and preimplantation embryos. BDNF or BDNF agonists may be administered to an individual, or to cells in vitro, to enhance cellular maturation, embryo growth and fertilization. Accordingly, compositions comprising BDNF are herein presented for use in promoting in vivo oocyte maturation as well as for use as a component in culture media for promoting preimplantation maturation of zygotes and embryos, for instance, for use with in vitro fertilization procedures and for the production of stem cells. Additionally, compounds that interfere with the binding of BDNF to its receptor may be administered to an individual to prevent oocyte maturation, thereby acting as a contraceptive. The BNDF receptor, TrkB, and BDNF also find use in the screening and design of agonists and antagonists for use in the methods of the invention.

Claims (15)

1. A method of enhancing the generation of an embryonic stem cell, the method comprising

contacting in vitro an immature oocyte with BDNF, or an agonist thereof in a dose effective to promote cytoplasmic changes essential for monospermic fertilization, processing the sperm and blastocyst development;

fertilizing said oocyte;

culturing said fertilized oocyte to the blastocyst stage in a growth media that promotes cellular proliferation but inhibits differentiation; and

generating an embryonic stem cell from undifferentiated inner mass cells from said blastocyst.

2. The method of claim 1 , wherein said growth media comprises a feeder cell layer.

3. The method of claim 1 , wherein said growth media does not comprise a feeder cell layer.

4. A method of enhancing the generation of an embryonic stem cell, the method comprising

contacting in vitro an enucleated oocyte transformed with the nucleus of another cell with BDNF, or an agonist thereof in a dose effective to promote

cytoplasmic changes essential for monospermic fertilization, processing the sperm and blastocyst development;

activating said oocyte;

culturing said fertilized oocyte to the blastocyst stage in a growth media that promotes cellular proliferation but inhibits differentiation; and

generating an embryonic stem cell from undifferentiated inner mass cells from said blastocyst.

5. The method of claim 4 , wherein said growth media comprises a feeder cell layer.

6. The method of claim 4 , wherein said growth media does not comprise a feeder cell layer.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 11, 2011
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025934/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2010
From: KAWAMURA, KAZUHIRO; HSUEH, AARON J.W.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 025229/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2010
From: MULDERS, SABINE M.
To: N.V. ORGANON
Reel/Frame 025229/0790 →
Continuity (3)
Division 11762606 · Jun 13, 2007
Provisional Application 60814475 · Jun 16, 2006
Related Publication 20110052599A1 · Mar 3, 2011